Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Installed Building Products, Inc.

IBP

FAVORABLE

May 30, 2026

Research Conclusion

At ~$215/share, Installed Building Products trades at a ~25–40% discount to our triangulated fair value range of $235–$300 (base $270), implying a positively-skewed risk/reward in a high-quality, founder-led roll-up that the market continues to price as a commodity housing cyclical. The recent QXO acquisition of TopBuild at 14x EBITDA removes IBP's primary public peer and re-anchors strategic value, while IBP's structural advantages — 30%+ ROIC, the IECC 2021 per-home revenue tailwind, ~$200M/yr non-cyclical M&A revenue floor, and a founder-CEO with ~13% ownership — remain intact post-Q1 2026 weather-driven miss. Verdict: Constructive at current levels with explicit acknowledgment that the housing cycle remains the dominant near-term beta.

Company Overview & Moat Assessment

Installed Building Products, Inc. (NYSE: IBP) is the #2 US installer of residential insulation and complementary building products (garage doors, gutters, shower doors, waterproofing), operating ~210+ branches across 48 states with ~$3.0B FY 2024E revenue, ~17% adjusted EBIT margins, and ~30% ROIC. The business model is two-engine: organic growth tied to US new single-family housing starts and energy-code mandates, plus a serial-acquirer roll-up that adds 10–13 small regional installers per year at 4–8x EBITDA from a fragmented universe of 5,000+ targets. Founded and still led by Jeff Edwards (CEO since 1977, ~13% owner), IBP has grown revenue every single year since its 2014 IPO including through the COVID housing shock.

▲ Bull Case

  • ROIC durability is structurally underappreciated. IBP held 30%+ ROIC through the 2023 housing slowdown when starts fell 15% from peak. The combination of asset-light branches, scale purchasing discount on insulation, IECC 2021 per-home revenue uplift, and disciplined acquisitions at 4–7x EBITDA produces ~22% returns on incremental capital deployed — a compounding flywheel that survives every modern cycle.
  • Non-cyclical M&A engine adds $170–230M of revenue per year regardless of housing. IBP has averaged 10–13 deals/year for 5+ consecutive years through COVID, the 2022 rate shock, and the 2023 slowdown. With BLD removed from public-installer competition for sellers, IBP's relative position in the seller market strengthens, not weakens.
  • Multiple gap to strategic-buyer comp is now wide enough to matter. QXO paid 14x EBITDA for BLD; IBP trades at ~9.4x. Even at a justifiable strategic-control premium of 12x (still below BLD takeout), IBP would be worth ~$280/share. A strategic-interest disclosure event would re-rate the stock independent of organic fundamentals.

▼ Bear Case

  • Higher for longer suppresses housing starts through FY27 — if mortgage rates remain at 6.5%+ and SF starts stagnate at 900–950K, IBP's organic same-branch growth runs flat-to-negative for 2 more years, and the multiple compresses back to ~14x P/E on a housing cyclical narrative reset (Step_15 bear case → $151).
  • National homebuilder pricing power reasserts in a weaker market. D.R. Horton and Lennar account for an outsized share of IBP's volume; in a soft demand environment, they have proven willing to push back on installer pricing, potentially reversing 2021–2022 IECC-driven per-home revenue gains and compressing IBP gross margins from 32.7% toward 31%.
  • Acquisition multiple inflation from PE roll-up competition — if 5–6x EBITDA acquisitions creep to 8–9x as private equity competes harder for fragmented services, IBP's Stream B value compounder compresses from 22% incremental ROIC to ~15–17%, materially shrinking the M&A contribution to per-share intrinsic value.
Primary Debate on Wall Street

The Street is divided on whether IBP is a high-quality compounder priced as a cyclical (our variant view) or a housing cyclical correctly priced for the current rate environment (consensus view). Bulls argue ROIC of 30%+ has been demonstrated through cycle and deserves quality-compounder multiple of 19–22x; Bears argue 2026 organic growth deceleration proves IBP can't escape housing and deserves cyclical multiple of 13–16x. The QXO–BLD deal at 14x EBITDA partially settles this debate in the bulls' favor, validating that the cyclical multiple compression has gone too far. But Street tends to discount take-out scenarios in standalone valuation. Sub-debate: Whether IBP's commercial/heavy-commercial pivot is meaningful enough to materially de-cyclical the business.

Top Catalysts
  • Mortgage rate decline to 5.5–6.0% unlocking pent-up housing demand and accelerating SF starts to 1.1M+
  • QXO–BLD close in Q3 2026 removes IBP's primary public peer, structurally elevating IBP's strategic value and sparking strategic-interest speculation
  • IECC 2021 adoption by remaining ~20 states adds $800–2,000 per-home insulation revenue in covered geographies
  • Commercial / heavy-commercial growth offsetting residential weakness, providing a new organic growth lever
  • Counter-cyclical acquisition acceleration if soft housing market produces willing sellers at 4–5x EBITDA
  • Spray-foam mix shift continues lifting per-home revenue and gross margin
Top Risks
  • Mortgage rates stay at 7%+ through FY27 suppressing SF starts to 900–950K — primary base-case risk
  • Homebuilder pricing power assertion in soft demand environment — compresses gross margin 100–200bps
  • CEO succession — Jeff Edwards is irreplaceable; departure without credible successor triggers meaningful multiple compression
  • PE-driven acquisition multiple inflation (5–6x → 8–9x) eroding Stream B value and breaking M&A flywheel
  • Tariffs on building materials (steel, aluminum, petrochemicals) creating margin friction despite 60–90 day pass-through lag
  • 2008-style severe housing recession (low probability ~10% but non-zero; IBP compresses to $80–90)
  • Acquisition integration failures clustering in single year triggering goodwill impairment and undermining M&A narrative

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/IBP/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.